Entrada Therapeutics
TRDA
#7538
Rank
ยฃ0.29 B
Marketcap
ยฃ7.83
Share price
-1.37%
Change (1 day)
-53.60%
Change (1 year)

Revenue for Entrada Therapeutics (TRDA)

Revenue in 2025 (TTM): ยฃ48.33 Million

According to Entrada Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ46.12 Million. In 2024 the company made a revenue of ยฃ0.16 Billion an increase over the revenue in the year 2023 that were of ยฃ0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Entrada Therapeutics from 2021 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ48.33 M-71.22%
2024 ยฃ0.16 B65.87%
2023 ยฃ0.10 B
2022 N/A
2021 N/A